SUPN Other Disclosure
Khattar Jack A. · SEC Form 4 · Filed Nov 4, 2026
Other
Calculated transaction value
$0
Khattar Jack A. President, CEO
SUPN
Supernus
SUPN
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
SUPN daily price context
Close on/before transaction
--
Nov 2, 2026
First close after public filing
$26.74
Nov 5, 2026
Return after filing · so far
-2.17%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 958,100 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- J
- Form
- 4
- Filing identifier
- 0001539937-26-000016
Filing cohort
Transactions in this filing
Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN Current | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |